Advanced periodontitis — Stage III and IV — remains one of the most demanding conditions in clinical periodontics, where the choice between non-surgical periodontal therapy (NSPT) and surgical periodontal therapy (SPT) is frequently debated but rarely supported by large-scale comparative data, particularly in Asian populations. This retrospective cohort study from China addresses that gap directly.

The study enrolled 3,194 patients diagnosed with Stage III/IV periodontitis who underwent periodontal treatment between April 2017 and September 2022. Of these, 2,982 received NSPT and 212 underwent SPT. Clinical parameters — probing depth (PD), clinical attachment loss (CAL), and bleeding on probing (BOP) — were extracted from a hospital-based electronic periodontal record system. Statistical analyses included independent t-tests, linear regression, and multilevel models, with adjustments for age, sex, smoking status, and follow-up compliance. Mean follow-up duration was 1.56 years.

Over the observation period, SPT produced significantly greater reductions in all three clinical parameters compared to NSPT: PD reduction (1.16 ± 1.06 mm vs. 0.77 ± 0.81 mm), CAL gain (0.97 ± 1.13 mm vs. 0.68 ± 0.90 mm), and BOP percentage reduction (0.28% ± 0.27% vs. 0.23% ± 0.29%), all statistically significant (P < .01). These results confirm the short-term clinical superiority of surgical intervention in advanced disease. However, a critical nuance emerges when the time horizon is extended: beyond three years of follow-up, the differential advantage of SPT over NSPT diminishes substantially. The variable that most consistently predicted favorable long-term outcomes — regardless of treatment modality — was adherence to regular supportive periodontal care (SPC).

For the practicing periodontist or implantologist, the clinical implications are layered. In the short term, SPT delivers measurably better pocket reduction and attachment level improvement, making it the preferred option when rapid and substantial clinical change is required — for instance, prior to implant placement in a periodontally compromised patient. Yet the data caution against viewing surgery as the definitive solution: without structured maintenance, its gains erode. Conversely, NSPT supported by rigorous recall protocols can achieve long-term stability comparable to surgical outcomes. This repositions NSPT not as a second-best option, but as a viable primary strategy when patient compliance can be secured.

The study's strengths include its large sample size and use of a structured electronic record system. Its limitations are those inherent to retrospective design — potential selection bias, lack of randomization, and the relatively modest surgical cohort (n = 212) compared to the NSPT group. Generalizability to non-Chinese populations also warrants caution.

The bottom line: surgical therapy wins the short game; maintenance wins the long one. For clinicians managing advanced periodontitis, the decision between NSPT and SPT should be driven not only by pocket depth and disease severity, but by a realistic assessment of each patient's capacity for long-term adherence.